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Abstract
Background: The clinical diagnosis of influenza is difficult because it shares nonspecific symptoms with a variety of diseases.
Emergency departments and clinics were overwhelmed by a surge of anxious patients during the 2009 influenza A virus
(H1N1) outbreak. Our objective was to identify symptomatic predictors of influenza virus infection for patients with a
negative rapid diagnostic test.
Methodology/Principal Findings: We conducted a retrospective review of 805 patients who presented at Chang Gung
Memorial Hospital, from August 1, 2009, to September 30, 2009. Respiratory specimens from these patients were subjected
to rapid influenza tests and reverse-transcription polymerase chain reactions. In total, 36% of 308 children and 23% of 497
adults were positive for 2009 influenza A virus (H1N1) infection by polymerase chain reaction or virus culture. For pediatric
patients, sore throat and influenza-like illness significantly increased the odds of having 2009 influenza A virus (H1N1)
infection, by more than 3-fold (95% confidence interval (CI): 1.9–7.3) and 7-fold (95% CI: 4.00–14.2), respectively. For adult
patients, cough and constitutional symptoms increased the odds of having 2009 influenza A virus (H1N1) by greater than 5-
fold (95% CI: 3.1–10.2) and 3-fold (95% CI: 2.1–6.7), respectively. The negative likelihood ratio of the combination of fever
and cough was 0.096 (95% CI: 0.01–0.69) for children with negative results of rapid influenza diagnostic tests.
Conclusion/Significance: In influenza epidemic settings, clinicians should be aware that rapid influenza diagnostic tests are
relatively insensitive for the diagnosis of influenza virus infection. For patients with negative rapid influenza diagnostic tests,
those lacking fever and cough have a low probability of influenza virus infection. The management strategy should be made
individually and depend on the severity of illness.
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Introduction
Influenza virus infection is a major public-health problem that
affects 5–15% of the global population annually [1]. Given its
propensity for antigenic drifts and shifts, influenza has the capacity
to cause annual epidemics and occasional pandemics [2].
Appropriate and prompt diagnosis and therapy affect society as
well as individual patients, because local outbreaks may be detected
and control measures initiated [3]. However, influenza is difficult to
diagnose clinically because the symptoms are largely nonspecific
and a variety of diseases can cause similar symptoms. A symptom
complex for influenza-like illness (ILI) has been used as a predictive
tool for the diagnosisof influenzainfection at the primary-care level,
especially in influenza epidemic contexts. However, the sensitivity
and positive predictive values of such tools vary widely and depend
on the prevalence of influenza, the population tested, and the co-
circulation of other respiratory viruses in the community [4].
Several laboratory assays are available for the diagnosis of
influenza, including viral cultures, serology, rapid diagnostic (antigen)
testing, reverse-transcription polymerase chain reaction (RT-PCR),
and immunofluorescence assays [5–9]. Rapid antigen detection
assays, including chromatographic immunoassays, are used widely
because they are relatively easy to handle, less costly, and provide test
results in less than 15 min [8,10–12]. The sensitivity and specificity of
any test for influenza can vary depending on the laboratory
performing the test, test and specimen types, specimen quality, and
the timing of specimen collection in relation to illness onset.
A pandemic outbreak of a novel strain of influenza A (H1N1) virus,
first identified in Mexico, occurred from March 2009 onward [13–
15]. News of the pandemic led to a heightened awareness of the
consequences of influenza. Apprehension skyrocketed in the general
population and among healthcare providers, causing substantial
increases in the number of patient visits to hospital emergency
departments.
In Taiwan, 2009 influenza A (H1N1) virus became circulating
in the communities since July 2009. The Centers for Disease
Control of Taiwan (CDC- Taiwan) published the ‘‘Clinical
Treatment Guidelines for Influenza A (H1N1)’’ on August 17,
PLoS ONE | www.plosone.org 1 December 2011 | Volume 6 | Issue 12 | e281022009. According to the guidelines, oseltamivir was suggested to be
prescribed to patients who had influenza-like illness and also had
either a positive rapid influenza diagnostic test result, complicated
influenza, at-risk conditions for complications defined by the
World Health Organization (WHO), or hazardous signs defined
by CDC-Taiwan, and the medication would be provided by
CDC-Taiwan. But, the costs of rapid influenza diagnostic tests
were needed to be paid by patients themselves. Emergency
departments and clinics became overwhelmed by a surge of
anxious patients who presented with respiratory illnesses of varying
severity. The increased diagnostic testing needs caused increases in
the workload of hospital personnel and testing demands on
laboratory resources.
To reduce unnecessary diagnostic testing and demands on
laboratory resources in the context of influenza epidemics, we
undertook a comparative study to identify symptomatic predictors
of influenza virus infection, especially for patients with a negative
rapid diagnostic test.
Methods
Ethics Statement
This study was approved by the institutional review board of
Chang Gung Memorial Hospital. Informed consent was omitted
because the data were analyzed anonymously.
Definition of influenza virus infection
Influenza virus infection was defined as a positive result of
reverse-transcription polymerase chain reaction (RT-PCR) or
virus culture for influenza virus. Influenza-like illness was defined
according to the criteria proposed by CDC-Taiwan: the presence
of fever plus at least one upper-respiratory symptom (cough, sore
throat, rhinorrhea) and one constitutional symptom (headache,
malaise, myalgia) [16].
Study population
Between August 1 and September 30, 2009, at Chang Gung
Memorial Hospital, Taoyuan, Taiwan, a total of 805 patients (308
children, 497 adults) with suspected influenza virus infection
receiving both rapid influenza diagnostic test and RT-PCR for
influenza virus were enrolled in this study. Virus isolation and
identification was further performed for 132 of these patients. The
specimens were obtained either from nasopharyngeal or throat
swabs. The decision to collect a nasopharyngeal or throat swab
sample was made at the discretion of the individual treating
physician. These specimens were transported to the virology
laboratory and processed immediately. Overall, 317 (39%)
patients had influenza virus infection: 226 patients (111 children,
115 adults) had 2009 influenza A virus (H1N1) infection, 87
patients (28 children, 59 adults) had influenza A (H3N2) virus
infection, and four adult patients had influenza B virus infection.
In this study, we focused on the patients with 2009 influenza A
virus (H1N1) infection in terms of having a homogeneous group of
patients to study. 117 of 169 children and 202 of 319 adults with
negative results for influenza virus were randomly selected as
controls, with a ratio of 2 to 3 by an age interval of 10 years.
Figure 1 illustrates the patient inclusion process.
Rapid influenza test
All rapid influenza antigen tests were performed in the hospital’s
laboratories using the QuickVue Influenza A+B rapid influenza
antigen test (Quidel Corp., San Diego, CA, USA), according to the
manufacturer’s instructions.
Reverse-transcription polymerase chain reaction
We extracted viral nucleic acids from nasopharyngeal swab
specimens with the MagNA Pure LC Total Nucleic Acid Isolation
Kit (Roche Diagnostics, Mannheim, Germany), using the
manufacturer’s external lysis protocol and extraction reagents.
Figure 1. Flow chart of patient inclusion, including 226 cases of 2009 influenza A virus (H1N1) infection and 319 cases of non-
influenza controls. RIDT, rapid influenza diagnostic test; RT-PCR, reverse transcriptase polymerase chain reaction.
doi:10.1371/journal.pone.0028102.g001
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Master mix reagent (ABI). Influenza A/B master mix and
extracted RNA were subjected to RT-PCR in the presence of
influenza matrix gene-specific primers. An internal control assay
was performed with RNase P master mix containing RNase P
gene-specific primers. The reactions were performed and analyzed
with an ABI PRISM 7000/7900HT sequence detection system
(Applied Biosystems, Branchburg, NJ, USA) or Bio-Rad CFX 96
system (Bio-Rad Laboratories, Hercules, CA, USA) under the
following conditions: 30 min at 48uC and 10 min at 95uC,
followed by 45 cycles of 15 s at 95uC and 1 min at 60uC.
All samples showing positivity for influenza A were typed
further with influenza A swine (H1N1) nucleoprotein gene real-
time RT-PCR [17,18] . The detection limit of the influenza A/B
real-time RT-PCR was 10 copies/mL.
Data collection
Demographic data, underlying medical conditions known to be
risk factors for influenza-related complications [19], clinical
features at presentation, laboratory test results, radiographic
findings, influenza-related complications, and treatment course
of each patient were collected from their medical records.
Statistics
Statistical analyses were performed using the SPSS software
(SPSS, Inc. Chicago, IL, USA). Student’s t-test was used to
compare continuous variables and Fisher’s exact test was used to
compare dichotomous variables. Variables found to be significant
in univariate analyses were entered into a multivariate analysis
using a logistic regression model to identify independent factors
associated positively with influenza virus infection. Two-tailed p
values,0.05 were considered to indicate statistical significance.
We calculated the sensitivity, specificity, positive and negative
predictive values, and likelihood ratios (LR) for positive and
negative test results. Receiver operating characteristic curves were
plotted for single symptoms and various symptom combinations.
The diagnostic accuracy of single and combined symptoms was
assessed by calculating area under the receiver operating
characteristic (AUROC) curves.
Results
Among the 226 patients with 2009 influenza A virus (H1N1)
infection, the most common symptoms were fever and respiratory
symptoms. Gastrointestinal symptoms, including nausea/vomit-
ing, diarrhea, and abdominal pain, were observed in 36% of
pediatric patients and 17% of adult patients.
Children
Demographic information and underlying comorbid conditions
of the 111 children in the study sample are presented in Table 1.
Most (83%) children were older than 5 years of age. The mean age
of children with 2009 influenza A virus (H1N1) infection was
greater than that of children with non-influenza illnesses
(p,0.001). ILI was identified in 76% (84/111) of children with
2009 influenza A virus (H1N1) infection. Children with 2009
influenza A virus (H1N1) infection were less likely to have
underlying medical conditions known to be risk factors for severe
influenza [21] than were children with non-influenza illnesses.
Among the 111 children with 2009 influenza A virus (H1N1)
infection, 53 (48%) were admitted to the hospital. The mean
length of hospital stay was 4.3 d. Eighteen (34%, 18/53) children
had at least one underlying condition. Hospitalized children were
significantly younger (mean age: 8.5 vs. 12.1 years) and more likely
to have underlying conditions (p=0.034) than those who were not
hospitalized. Eight children (7.2%, 8/111) had influenza-associat-
ed complications. One child with mosaic monosomy 14 and
epilepsy developed frequent seizures, which resulted in rhabdo-
Table 1. Demographic characteristics and comorbidities in patients with non-influenza illness and 2009 influenza A virus (H1N1)
infection.
Characteristics Children Adults
Non-influenza
(n=117)
n (%)
2009 Influenza A
virus (H1N1)
(n=111) n (%) p
Non-influenza
(n=202)
n (%)
2009 Influenza A virus
(H1N1) (n=115) n (%) p
Age (years)
Mean (range) 5.1 (0.02–17.3) 10.2 (1.1–17.8) ,0.001 42.2 (19.3–97.1) 30.5 (18.1–83.5) ,0.001
,5 75 (64) 19 (17)
$65 ,0.001 29 (14) 2 (2) ,0.001
Male gender 64 (55) 77 (69) 0.023 72 (36) 53 (46) 0.067
Comorbid conditions 40 (34) 27 (24) 0.145 88 (44) 24 (21) 0.000
Asthma/COPD 21 (18) 21 (19) 0.825 19 (9) 7 (6) 0.300
Cardiac/cardiovascular
disease
3 (3) 1 (1) 0.622 18 (9) 7 (6) 0.370
Neurological impairment 9 (8) 4 (4) 0.281
Diabetes mellitus 0 1 (1) 0.485 24 (12) 6 (5) 0.051
Hypertension 36 (18) 7 (6) 0.003
Dyslipidemia 12 (6) 2 (2) 0.080
Immunocompromised 1 (1) 0 1 23 (11) 3 (3) 0.006
Hospitalization 53 (49) 11 (10)
COPD, chronic obstructive pulmonary disease.
doi:10.1371/journal.pone.0028102.t001
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previously healthy children developed influenza-associated pneu-
monia. A previously healthy 4-year-old female developed acute
myocarditis and died 2 days later.
Laboratory tests were performed on specimens collected from
65 (59%, 65/111) children. Eighteen children had leukocyte
counts ,5000/mL and only three had leukocyte counts .15000/
mL. Children with 2009 influenza A virus (H1N1) infection were
more likely to have leucopenia than were children with non-
influenza illness (p=0.015). Antiviral therapy with oseltamivir was
administered to 84 (76%, 84/111) children, the youngest of whom
was 1.1 years of age. Thirty-eight (34%, 38/111) children received
parenteral or oral antibacterial therapy. Children with 2009
influenza A virus (H1N1) infection were more likely to receive
oseltamivir or antibiotic treatment than were children with non-
influenza illness (p,0.001).
Univariate analysis (Table 2) showed that children with 2009
influenza A virus (H1N1) infection were more likely than those
who did not have influenza to have cough (p=0.001), sore throat
(p,0.001), headache (p,0.001), malaise (p,0.001), myalgia
(p,0.001), and ILI (p,0.001). Multivariate analysis showed that
sore throat and ILI significantly increased the odds of having 2009
influenza A virus (H1N1) infection by more than 3-fold (OR=3.9,
95% CI: 1.9–7.3) and 7-fold (OR=7.5, 95% CI: 4.00–14.2),
respectively.
We further evaluated the performance of individual symptoms
and symptom combinations as well as the rapid diagnostic test for
the diagnosis of influenza infection (Table 3). ILI showed a
sensitivity of 78% and a specificity of 77% in differentiating 2009
influenza A virus (H1N1) infection from non-influenza illness. No
single symptom or a combination yielded a positive LR.10 (data
were not shown). The specificity and sensitivity of the rapid
influenza diagnostic test (RIDT) was 100% and 57%, respectively.
The sensitivity of the rapid influenza diagnostic test was lower than
any individual clinical symptom or a combination except for
headache and malaise alone. Considering relative insensitivity of
the rapid influenza diagnostic test, we further evaluated the
performance of individual symptoms and symptom combinations
in the diagnosis of influenza virus infection for those with a
negative result of RIDT but a positive result of RT-PCR. Table 4
lists the LRs for various combinations of symptoms in pediatric
patients. There was no statistical significance in the value of
AUROC between a combination of cough and any constitutional
symptom and ILI (p=0.29). As well, no single symptom or any
combination yielded a positive LR.10. The negative LR of the
combination of fever and cough was 0.096 (95% CI: 0.01–0.69),
which was lower than those of other symptoms and combinations,
including ILI.
Adults
Demographic information and underlying comorbid conditions
of the 115 adult patients are presented in Table 1. Only two
patients were more than 65 years of age. The mean age of
individuals with 2009 influenza A virus (H1N1) infection was
lower than that of patients with non-influenza illness (p,0.001).
ILI was identified in 72% (83/115) of the adult patients with 2009
influenza A virus (H1N1) infection. Adult patients with 2009
influenza A virus (H1N1) infection were less likely than those with
non-influenza illness to have underlying medical conditions known
to be risk factors for severe influenza (p,0.001) [21].
Eleven (10%, 11/115) of the adult patients with 2009 influenza
A virus (H1N1) infection were admitted to the hospital, eight
(73%, 8/11) of whom had at least one underlying condition. The
mean length of hospital stay was 5.7 d, excepting one patient who
Table 2. Presenting symptoms in patients with non-influenza illness and 2009 influenza A virus (H1N1) infection.
Symptoms Children Adults
Non-influenza
(n=117)
n (%)
2009
Influenza
A (H1N1)
(n=111)
n (%)
Univariate
analysis
p
Multivariate
analysis
p
Non-influenza
(n=202)
n (%)
2009
Influenza
A (H1N1)
(n=115)
n (%)
Univariate
analysis
p
Multivariate
analysis
p
Fever 110 (94) 110 (99) 0.066 156 (77) 101 (88) 0.021
Respiratory
symptoms
Cough 94 (80) 105 (95) 0.001 109 (54) 98 (85) ,0.001 ,0.001
Coryza 74 (63) 79 (71) 0.203 66 (33) 38 (33) 0.970
Sore throat 21 (18) 64 (58) ,0.001 ,0.001 93 (46) 75 (65) 0.001
Any 102 (87) 109 (98) 0.002 153 (76) 110 (96) ,0.001
Constitutional
symptoms
Headache 18 (15) 48 (43) ,0.001 38 (19) 26 (23) 0.418
Malaise 7 (6) 26 (23) ,0.001 40 (20) 35 (30) 0.032
Myalgia 24 (21) 65 (59) ,0.001 96 (48) 70 (61) 0.025
Any 36 (31) 86 (77) ,0.001 120 (59) 95 (85) ,0.001 ,0.001
Gastrointestinal
symptoms
Nausea/
vomiting
34 (29) 26 (23) 0.334 18 (9) 14 (12) 0.354
Abdominal pain 16 (14) 14 (13) 0.812 12 (6) 0 0.005
Diarrhea 24 (21) 13 (12) 0.072 22 (11) 9 (8) 0.377
Any 54 (46) 40 (36) 0.121 41 (20) 19 (17) 0.409
Influenza-like
illness
27 (23) 84 (76) ,0.001 ,0.001 70 (35) 83 (72) ,0.001
doi:10.1371/journal.pone.0028102.t002
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infection.
Symptoms and signs non-influenza illness vs.2009 influenza A virus (H1N1) infection
children adults
Sensitivity (%) Specificity (%) Sensitivity (%) Specificity (%)
Single symptom or sign Fever 99 6 88 23
Cough 95 20 85 46
Coryza 71 34 33 67
Sore throat 58 82 65 54
Any respiratory symptom 98 13 96 24
Headache 43 85 23 81
Malaise 23 94 30 80
Myalgia 59 80 61 52
Any constitutional symptom 78 69 83 40
Symptom and sign combinations Fever + cough 94 23 74 59
Any respiratory + any constitutional symptom 77 74 79 56
Fever + any respiratory symptom 97 17 84 43
Fever + any constitutional symptom 77 73 76 53
Cough + any constitutional symptom 74 78 70 71
Influenza-like illness 76 77 72 65
Rapid influenza diagnostic test 57 100 38 100
doi:10.1371/journal.pone.0028102.t003
Table 4. Sensitivity and specificity of symptom and sign combinations for the identification of 2009 influenza A virus (H1N1)
infection in patients with negative rapid influenza diagnostic tests (RIDTs).
Symptoms and signs
Non-influenza illness with RIDT (2) and RT-PCR (2) vs. H1N1 with RIDT (2) and RT-
PCR (+)
Children Adults
AUROC
(%)
Positive LR
(95% CI)
Negative LR
(95% CI)
AUROC
(%)
Positive LR
(95% CI)
Negative LR
(95% CI)
Single symptom or sign Fever 51.9 1.04 (0.98–1.11) 0.37 (0.05–2.93) 52.6 1.07 (0.93–1.22) 0.78 (0.44–1.37)
Cough 59.8 1.25 (1.14–1.36) 69.3 1.71 (1.49–1.98) 0.16 (0.07–0.38)
Coryza 50.6 1.02 (0.79–1.32) 0.97 (0.61–1.53) 53.9 1.12 (0.94–1.32) 0.76 (0.48–1.20)
Sore throat 71.0 3.34 (2.12–5.26) 0.49 (0.34–0.70) 62 1.52 (1.23–1.88) 0.55 (0.37–0.81)
Any respiratory symptom 56.4 1.15 (1.07–1.23) 61.9 1.31 (1.22–1.42)
Headache 63.4 2.75 (1.59–4.74) 0.68 (0.53–0.89) 50.6 1.01 (0.89–1.15) 0.94 (0.52–1.69)
Malaise 62.6 5.21 (2.25–12.0) 0.73 (0.60–0.90) 58.5 1.86 (1.22–2.82) 0.79 (0.65–0.96)
Myalgia 69.7 2.92 (1.90–4.48) 0.50 (0.35–0.73) 54.1 1.17 (0.91–1.51) 0.84 (0.63–1.14)
Any constitutional symptom 74.6 2.60 (1.91–3.55) 0.29 (0.16–0.52) 60.6 1.36 (1.15–1.59) 0.47 (0.28–0.80)
Symptom and sign combinations Fever + cough 60.4 1.27 (1.14–1.42) 0.096 (0.01–0.69) 67.2 1.85 (1.49–2.29) 0.42 (0.27–0.65)
Any respiratory + any
constitutional symptom
77.2 3.12 (2.22–4.39) 0.27 (0.15–0.49) 67.2 1.82 (1.50–2.20) 0.34 (0.21–0.57)
Fever + any respiratory symptom 57.4 1.18 (1.07–1.30) 0.13 (0.02–0.94) 62.6 1.44 (1.22–1.69) 0.41 (0.24–0.71)
Fever + any constitutional
symptom
75.2 2.84 (2.04–3.97) 0.31 (0.18–0.53) 61 1.47 (1.18–1.82) 0.58 (0.40–0.85)
Cough + any constitutional
symptom
78.9 3.60 (2.49–5.21) 0.26 (0.14–0.46) 73.1 2.61 (2.02–3.38) 0.35 (0.23–0.53)
Influenza-like illness 77.3 3.37 (2.34–4.85) 0.29 (0.17–0.50) 67.1 1.98 (1.55–2.54) 0.47 (0.33–0.69)
RIDT, rapid influenza diagnostic test; RT-PCR, reverse transcriptase polymerase chain reaction; AUROC, area under the receiver operating characteristic curve; LR,
likelihood ratio.
doi:10.1371/journal.pone.0028102.t004
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significantly older (mean age: 52.6 vs. 28.1 years) and more likely
to have underlying conditions (p,0.001) than those who were not
hospitalized. Seven (6%, 7/115) patients had influenza-associated
complications; all had pneumonia. Five (71%, 5/7) of these
patients had other underlying medical conditions. Two developed
respiratory failure, requiring admission to the intensive care unit
and mechanical ventilation. No death occurred.
Laboratory test results were available for 24 (21%, 24/115)
patients. Only two cases had leukocyte counts ,5000/mL and
none had a leukocyte count .15000/mL. There was no significant
difference in the incidence rate of leucopenia between adult
patients with 2009 influenza A virus (H1N1) infection and those
with non-influenza illness (p=0.732). Antiviral therapy with
oseltamivir was administered to 66 (57%, 66/115) patients.
Nineteen (17%, 19/115) patients received parenteral or oral
antibacterial therapy, with or without oseltamivir treatment.
Similar to the results in children, adult patients with 2009 H1N1
infection were more likely than those with non-influenza illness to
receive oseltamivir or antibiotic treatment (p,0.001).
Univariate analysis (Table 2) showed that adults with 2009
influenza A virus (H1N1) infection were more likely than those
who did not have influenza to have fever (p=0.021), cough
(p,0.001), sore throat (p=0.001), malaise (p=0.032), myalgia
(p=0.025), and ILI (p,0.001), and less likely to have abdominal
pain (p=0.005). Multivariate analysis showed that cough and
constitutional symptoms (headache, malaise, myalgia) increased
the odds of having 2009 influenza A virus (H1N1) infection by
more than 5-fold (OR=5.6, 95% CI: 3.1–10.2) and 3-fold
(OR=3.7, 95% CI: 2.1–6.7), respectively.
We further evaluated the performance of individual symptoms
and symptom combinations as well as the rapid diagnostic test for
the diagnosis of influenza infection (Table 3). ILI showed a
sensitivity of 69% and a specificity of 65% in differentiating 2009
influenza A virus (H1N1) infection from non-influenza illness. As
seen in the children, no single symptom or any combination
yielded a positive LR.10 (data were not shown). The specificity
and sensitivity of the rapid influenza diagnostic test in the diagnosis
of influenza was 100% and 38%, respectively. The sensitivity of
the rapid influenza diagnostic test was lower than any individual
clinical symptom or a combination except for coryza, headache
and malaise. Table 4 lists the LRs for various combinations of
symptoms associated with 2009 influenza A virus (H1N1) infection
in adult patients with negative results of RIDTs. A combination of
cough and any constitutional symptom yielded an AUROC of
73.1%, which was larger than other symptom or combination,
including ILI (67.1%, p,0.05). No single symptom or any
combination yielded a positive LR.10 or a negative LR,0.1.
Discussion
Acute respiratory illnesses are the leading cause of outpatient
medical visits among patients of all ages. Although it is neither
necessary nor cost-effective to establish a specific viral cause for
most respiratory viral diseases, it is important to distinguish
influenza from other respiratory viruses because the influenza virus
is associated with higher morbidity and mortality and early
antiviral treatment can reduce the risk of severe illness or death
[20–26]. In addition, the rapid detection of influenza viruses also
can prompt strategies to prevent transmission to other patients.
Among the laboratory-based methods of influenza diagnosis, rapid
influenza diagnostic tests have been adopted increasingly by
clinicians because they provide test results within 15 min.
Symptomatic predictors of influenza have been examined using
surveys and clinical trials and in practice settings [27,28]. The
sensitivity of clinical predictors for influenza varies depending on a
multitude of factors, including the prevalence of disease, age,
underlying illnesses, duration of symptoms prior to consultation,
and the vaccination rate in the population tested. Thus, the use of
symptomatic predictors should be limited to periods of known
influenza virus circulation [3,4,28,29]. Most studies, including
ours, have been conducted in the context of community outbreaks
of seasonal influenza. In the present study, sore throat and ILI
increased the probability of 2009 influenza A virus (H1N1)
infection in pediatric patients. Among adults, cough and
constitutional symptoms increased the probability of 2009
influenza A virus (H1N1) infection.
Although previous studies have shown that fever and cough
were better predictors of influenza virus infection, no symptom or
combination has been found to be sufficiently specific for the
diagnosis of influenza virus infection [3,4,28,29]. This was also
true in the present study. A wide range of sensitivities of the rapid
influenza tests have been reported, whereas specificities have been
reported to be high [6,9]. In this study, we found that the rapid
influenza diagnostic test had relatively low sensitivity (38–57%) but
excellent specificity (100%) for the detection of 2009 influenza A
virus (H1N1) infection, consistent with the study by Uyeki et al
[30]. Compared with any symptoms or combinations, the
sensitivity of the rapid influenza diagnostic test was lower. Because
of the lower sensitivity and moderate negative predictive value
(71–74%) of rapid influenza diagnostic tests, we undertook a
further evaluation to identify symptomatic predictors for patients
with negative results of RIDT. We found that a combination of
cough and any constitutional symptom was more accurate than
other symptoms or combinations in predicting 2009 influenza A
virus (H1N1) infection in children and adults with negative RIDT
results. However, the positive predictive values were only 58% and
47%, respectively. In contrast, we found that the combination of
fever and cough had a sufficiently negative LR (0.096) to exclude
the probability of 2009 influenza A virus (H1N1) infection in
pediatric patients with negative RIDT results, and had a negative
predictive value (NPV) of 87.6% in adult patients. These results
indicate that without fever and cough, the probability of influenza
virus infection in patients with negative RIDT results, was low, to
a level of 10% or so. The sensitivity and predictive values of ILI
criteria for the diagnosis of influenza have varied among studies,
with positive predictive values ranging from 23% to 81% [28,31].
In the present study, a combination of cough and any
constitutional symptom had a better sensitivity and positive
predictive value than the ILI criteria for the diagnosis of influenza
in patients with negative RIDT results. Further prospective studies
may be needed to validate our findings.
For a retrospective study in nature, there are intrinsic limitations
in the current study. First, all the symptoms and signs were
collected from the medical charts, which were recorded by the
physicians but not by a designed checklist, so some symptoms and
signs may be missed. Second, the timings of samplings for
diagnostic tests were inconsistent, which may affect the accuracy
rate of diagnostic tests and the subsequent analyses. Third, for the
homogeneity of patients, we only studied the patients with 2009
influenza A virus (H1N1) infection, so whether the results
presented here can be applied to other subtypes of influenza virus
infection needs further observations. Forth, the study was
conducted during the epidemic of influenza, so it should be more
cautious when applying these results during non-epidemic. In
contrast, we not only evaluated the patients with influenza virus
infection, but also the influenza-infected patients with a negative
2009 Influenza A Virus (H1N1) Cases in Taiwan
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clinicians in daily clinical practice.
Conclusions
Clinical symptoms alone are inadequate to confirm the
diagnosis of influenza. Clinicians must pay attention to survey
data to recognize whether influenza viruses are circulating. In
influenza epidemic settings, clinicians should be aware that rapid
influenza diagnostic tests are relatively insensitive for the diagnosis
of influenza virus infection. For patients with negative rapid
influenza diagnostic results, those lacking fever and cough have a
low probability of influenza virus infection. The best management
strategy should be made on a case-by-case basis and depend on the
severity of illness.
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